Views

CrossRef citations to date

Altmetric

Original Articles: Clinical

Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens

Paola TacchettiDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Michele CavoDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, ItalyCorrespondence[email protected]

Serena RocchiDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Annalisa PezziDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Lucia PantaniDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Annamaria BrioliDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Nicoletta TestoniDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Carolina TerragnaDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Beatrice Anna ZannettiDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Katia MancusoDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Giulia MarzocchiDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Enrica BorsiDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Marina MartelloDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Ilaria RizzelloDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Elena ZamagniDepartment of Experimental, Diagnostic and Specialty Medicine, “Seràgnoli” Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

show all

Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date